Market revenue in 2022 | USD 41.9 million |
Market revenue in 2030 | USD 60.3 million |
Growth rate | 4.7% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , Saudi Arabia
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.29% in 2022. Horizon Databook has segmented the South Africa orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
In South Africa, the prevalence of osteoarthritis accounts for between 29.5% and 82.7% in adults over 65 years of age in rural settings and 55.1% in urban settings. The prevalence of osteoarthritis is high in the country, which is likely to significantly contribute to market growth over the forecast period.
The growing adoption of minimally invasive surgeries can further accelerate market growth. In 2016, a knee replacement operation was conducted using the advanced Mako robotic-arm for the first time in South Africa. Approximately 8,000 to 10,000 total knee replacements take place in the country annually, which can promote overall market growth.
The country is well-positioned as an ideal medical tourism destination, as it possesses an established and underutilized private healthcare sector. Thereby, South Africa is growing in popularity as a key medical tourism destination, which is leading to a positive impact on the market. SAHPRA, the regulatory authority, controls licensing of medical devices and their registration in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into South Africa orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account